Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Amanda R Walter, FNP
Nurse Practitioner · MILWAUKIE, OR · NPI 1609232248
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 434 | 49 |
| Memantine Hcl | Memantine Hcl | 336 | 33 |
| Gabapentin | Gabapentin | 325 | 33 |
| Donepezil Hcl | Donepezil Hcl | 278 | 33 |
| Amlodipine Besylate | Amlodipine Besylate | 226 | 25 |
| Oxycodone Hcl | Oxycodone Hcl | 226 | 59 |
| Levothyroxine Sodium | Levothyroxine Sodium | 217 | 24 |
| Furosemide | Furosemide | 184 | 26 |
| Lisinopril | Lisinopril | 175 | 16 |
| Trazodone Hcl | Trazodone Hcl | 148 | 25 |
| Eliquis | Apixaban | 146 | 20 |
| Metoprolol Succinate | Metoprolol Succinate | 146 | 19 |
| Omeprazole | Omeprazole | 138 | 21 |
| Risperidone | Risperidone | 132 | 11 |
| Losartan Potassium | Losartan Potassium | 124 | 15 |
| Potassium Chloride | Potassium Chloride | 115 | 17 |
| Metformin Hcl | Metformin Hcl | 113 | 11 |
| Pantoprazole Sodium | Pantoprazole Sodium | 111 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 104 | 32 |
| Mirtazapine | Mirtazapine | 102 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 97 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 91 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 88 | 11 |
| Sertraline Hcl | Sertraline Hcl | 81 | 12 |
| Metoprolol Tartrate | Metoprolol Tartrate | 79 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 77 | suppressed |
| Simvastatin | Simvastatin | 77 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 72 | 12 |
| Aripiprazole | Aripiprazole | 68 | suppressed |
| Pregabalin | Pregabalin | 68 | suppressed |
| Spironolactone | Spironolactone | 68 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 68 | 12 |
| Jardiance | Empagliflozin | 66 | suppressed |
| Carvedilol | Carvedilol | 65 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 64 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 64 | suppressed |
| Famotidine | Famotidine | 62 | suppressed |
| Rivastigmine | Rivastigmine | 62 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 60 | 31 |
| Alendronate Sodium | Alendronate Sodium | 60 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 59 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 58 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 58 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 53 | suppressed |
| Perphenazine | Perphenazine | 49 | suppressed |
| Finasteride | Finasteride | 47 | suppressed |
| Ondansetron Odt | Ondansetron | 47 | 32 |
| Baclofen | Baclofen | 40 | suppressed |
| Methadone Hcl | Methadone Hcl | 40 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 40 | suppressed |
| Oxycontin | Oxycodone Hcl | 39 | suppressed |
| Lorazepam | Lorazepam | 38 | suppressed |
| Myrbetriq | Mirabegron | 37 | suppressed |
| Torsemide | Torsemide | 37 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 35 | suppressed |
| Meloxicam | Meloxicam | 34 | suppressed |
| Clonazepam | Clonazepam | 33 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 33 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 32 | suppressed |
| Lamotrigine | Lamotrigine | 32 | suppressed |
| Nyamyc | Nystatin | 32 | 19 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 31 | 17 |
| Carbamazepine Er | Carbamazepine | 30 | suppressed |
| Clozapine | Clozapine | 30 | suppressed |
| Xarelto | Rivaroxaban | 30 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 29 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 28 | 27 |
| Cephalexin | Cephalexin | 28 | 22 |
| Rivastigmine | Rivastigmine Tartrate | 28 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 28 | 18 |
| Atenolol | Atenolol | 27 | suppressed |
| Olanzapine | Olanzapine | 27 | suppressed |
| Allopurinol | Allopurinol | 26 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 25 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 24 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 24 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 24 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 24 | 19 |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 23 | 14 |
| Prednisone | Prednisone | 22 | 11 |
| Bupropion Xl | Bupropion Hcl | 21 | suppressed |
| Methimazole | Methimazole | 21 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 21 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 21 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 20 | suppressed |
| Mirabegron Er | Mirabegron | 20 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 19 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 18 | suppressed |
| Benzonatate | Benzonatate | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 18 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 17 | 15 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 17 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Estradiol | Estradiol | 17 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 16 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 16 | suppressed |
| Sucralfate | Sucralfate | 16 | suppressed |
| Calcitriol | Calcitriol | 15 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Lubiprostone | Lubiprostone | 15 | suppressed |
| Methotrexate | Methotrexate Sodium | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 15 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 15 | suppressed |
| Rybelsus | Semaglutide | 15 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 15 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 15 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Vitamin B-1 | Thiamine Hcl | 14 | suppressed |
| Azithromycin | Azithromycin | 13 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Ezetimibe | Ezetimibe | 13 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 13 | suppressed |
| Lactulose | Lactulose | 13 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 13 | suppressed |
| Lorazepam Intensol | Lorazepam | 13 | 13 |
| Methenamine Hippurate | Methenamine Hippurate | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 12 | 12 |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 12 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 12 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 12 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 12 | suppressed |
| Rexulti | Brexpiprazole | 12 | suppressed |
| Risperidone Odt | Risperidone | 12 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 12 | suppressed |
| Belbuca | Buprenorphine Hcl | 11 | suppressed |
| Buprenorphine | Buprenorphine | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Ozempic | Semaglutide | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error